California State Teachers Retirement System (CalSTRS)’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-92,880
| Closed | -$282K | – | 3075 |
|
|
2024
Q4 | $282K | Sell |
92,880
-1,283
| -1% | -$5.59K | ﹤0.01% | 2304 |
|
|
2024
Q3 | $489K | Sell |
94,163
-3,161
| -3% | -$15.7K | ﹤0.01% | 2129 |
|
|
2024
Q2 | $250K | Sell |
97,324
-169
| -0.2% | -$577 | ﹤0.01% | 2348 |
|
|
2024
Q1 | $480K | Buy |
97,493
+8,668
| +10% | +$51.3K | ﹤0.01% | 2177 |
|
|
2023
Q4 | $781K | Sell |
88,825
-3,850
| -4% | -$31.5K | ﹤0.01% | 1970 |
|
|
2023
Q3 | $1.06M | Sell |
92,675
-8,859
| -9% | -$170K | ﹤0.01% | 1757 |
|
|
2023
Q2 | $2.57M | Sell |
101,534
-782
| -0.8% | -$24.4K | ﹤0.01% | 1346 |
|
|
2023
Q1 | $3.3M | Sell |
102,316
-432
| -0.4% | -$13.5K | ﹤0.01% | 1181 |
|
|
2022
Q4 | $1.9M | Buy |
102,748
+4,892
| +5% | +$112K | ﹤0.01% | 1504 |
|
|
2022
Q3 | $2.64M | Buy |
97,856
+9,642
| +11% | +$196K | ﹤0.01% | 1262 |
|
|
2022
Q2 | $1.22M | Sell |
88,214
-333
| -0.4% | -$5.13K | ﹤0.01% | 1812 |
|
|
2022
Q1 | $1.73M | Sell |
88,547
-7,478
| -8% | -$113K | ﹤0.01% | 1724 |
|
|
2021
Q4 | $1.57M | Buy |
96,025
+2,490
| +3% | +$41.5K | ﹤0.01% | 1880 |
|
|
2021
Q3 | $2.61M | Sell |
93,535
-3,264
| -3% | -$93.1K | ﹤0.01% | 1571 |
|
|
2021
Q2 | $2.87M | Buy |
96,799
+1,906
| +2% | +$55K | ﹤0.01% | 1560 |
|
|
2021
Q1 | $2.65M | Sell |
94,893
-368
| -0.4% | -$10.2K | ﹤0.01% | 1575 |
|
|
2020
Q4 | $2.7M | Buy |
95,261
+26
| +0% | +$673 | ﹤0.01% | 1466 |
|
|
2020
Q3 | $2.39M | Buy |
95,235
+9,610
| +11% | +$252K | ﹤0.01% | 1402 |
|
|
2020
Q2 | $2.09M | Buy |
85,625
+7,175
| +9% | +$142K | ﹤0.01% | 1445 |
|
|
2020
Q1 | $1.16M | Buy |
78,450
+9,832
| +14% | +$203K | ﹤0.01% | 1609 |
|
|
2019
Q4 | $1.11M | Hold |
68,618
| – | – | ﹤0.01% | 1899 |
|
|
2019
Q3 | $892K | Buy |
68,618
+819
| +1% | +$10K | ﹤0.01% | 1991 |
|
|
2019
Q2 | $879K | Buy |
67,799
+8,542
| +14% | +$108K | ﹤0.01% | 2048 |
|
|
2019
Q1 | $934K | Buy |
59,257
+7,893
| +15% | +$137K | ﹤0.01% | 1976 |
|
|
2018
Q4 | $1.03M | Buy |
51,364
+1,158
| +2% | +$25.5K | ﹤0.01% | 1883 |
|
|
2018
Q3 | $1.25M | Sell |
50,206
-17
| -0% | -$462 | ﹤0.01% | 1925 |
|
|
2018
Q2 | $1.38M | Buy |
50,223
+9,233
| +23% | +$278K | ﹤0.01% | 1850 |
|
|
2018
Q1 | $1.26M | Buy |
40,990
+4,858
| +13% | +$156K | ﹤0.01% | 1825 |
|
|
2017
Q4 | $1.29M | Sell |
36,132
-390
| -1% | -$11.2K | ﹤0.01% | 1854 |
|
|
2017
Q3 | $1.01M | Sell |
36,522
-3,248
| -8% | -$78.7K | ﹤0.01% | 2008 |
|
|
2017
Q2 | $1.05M | Sell |
39,770
-500
| -1% | -$11.1K | ﹤0.01% | 2025 |
|
|
2017
Q1 | $838K | Sell |
40,270
-1,800
| -4% | -$37K | ﹤0.01% | 2182 |
|
|
2016
Q4 | $871K | Sell |
42,070
-1,200
| -3% | -$20.1K | ﹤0.01% | 2194 |
|
|
2016
Q3 | $701K | Buy |
43,270
+400
| +0.9% | +$5.81K | ﹤0.01% | 2300 |
|
|
2016
Q2 | $583K | Buy |
42,870
+4,076
| +11% | +$72.1K | ﹤0.01% | 2369 |
|
|
2016
Q1 | $677K | Buy |
38,794
+4,828
| +14% | +$98.3K | ﹤0.01% | 2244 |
|
|
2015
Q4 | $1.16M | Buy |
33,966
+5,492
| +19% | +$190K | ﹤0.01% | 1894 |
|
|
2015
Q3 | $847K | Sell |
28,474
-100
| -0.3% | -$3.04K | ﹤0.01% | 2089 |
|
|
2015
Q2 | $914K | Buy |
28,574
+12,634
| +79% | +$325K | ﹤0.01% | 2167 |
|
|
2015
Q1 | $330K | Hold |
15,940
| – | – | ﹤0.01% | 2687 |
|
|
2014
Q4 | $270K | Buy |
15,940
+68
| +0.4% | +$1.19K | ﹤0.01% | 2833 |
|
|
2014
Q3 | $307K | Buy |
15,872
+3,272
| +26% | +$85.3K | ﹤0.01% | 2714 |
|
|
2014
Q2 | $428K | Hold |
12,600
| – | – | ﹤0.01% | 2594 |
|
|
2014
Q1 | $397K | Buy |
+12,600
| New | +$394K | ﹤0.01% | 2560 |
|
Other funds holding RVNC
California State Teachers Retirement System (CalSTRS)'s RVNC Position: Q1 2025 in Review
California State Teachers Retirement System (CalSTRS) sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 92,880 shares — an estimated $282K sold.
California State Teachers Retirement System (CalSTRS) first reported a position in RVNC in Q1 2014 and held it in 44 quarters. The position peaked at $3.3M in Q1 2023. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.
- California State Teachers Retirement System (CalSTRS) reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
- California State Teachers Retirement System (CalSTRS) sold 92,880 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $282K.
- California State Teachers Retirement System (CalSTRS) first reported a position in Revance Therapeutics, Inc. in Q1 2014 and held it in 44 quarters.
- California State Teachers Retirement System (CalSTRS)'s Revance Therapeutics, Inc. position peaked at $3.3M in Q1 2023.
- 1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2025, filed 15 May 2025.